Insider trades
Hans Hull, Chief Officer of Pliant Therapeutics PLRX, has filed 0 purchases and 8 sales on the open market. The latest trade was on 25/01/23.
Hans Hull
Chief Business Officer
- Company
- Pliant Therapeutics PLRX
- First filing
- 23/01/27
- Trades
- 21 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- No record
- Last trade
- 25/01/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 25/01/17 | 25/01/22 | 15,936 sh | $11.20 | $178,483.2 | −7.0% | |
| Open-market sale10b5-1 plan | 24/07/10 | 24/07/12 | 9,900 sh | $11.56 | $114,444 | −4.2% | |
| Open-market sale10b5-1 plan | 24/01/17 | 24/01/19 | 9,786 sh | $17.23 | $168,612.78 | −5.0% | |
PLRX | Open-market sale10b5-1 plan | 23/08/03–23/08/04 | 23/08/07 | 34,919 sh3 trades | $20.01avg. | $698,580.5 | No record |
| Open-market sale10b5-1 plan | 23/07/17 | 23/07/19 | 17,937 sh | $18.01 | $323,045.37 | −7.6% | |
| Open-market sale10b5-1 plan | 23/03/30 | 23/04/03 | 9,036 sh | $26.52 | $239,634.72 | −4.3% |